Treatment of pulmonary hypertension with carbonic anhydrase inhibitors

Details for Australian Patent Application No. 2008267058 (hide)

Owner Vivus, Inc.

Inventors Tam, Peter; Wilson, Leland; Peterson, Craig; Najarian, Thomas

Agent FB Rice

Pub. Number AU-B-2008267058 ( Modified Examination )

PCT Pub. Number WO2008/156550

Priority 11/818,306 13.06.07 US

Filing date 30 May 2008

Wipo publication date 24 December 2008

Acceptance publication date 23 August 2012

International Classifications

A61K 31/7048

A61K 31/137 - Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine

A61K 31/423 - condensed with carbocyclic rings

A61K 31/433 - Thiadiazoles

A61K 45/06 Medicinal preparations containing active ingredients not provided for in groups

A61P 9/12 Drugs for disorders of the cardiovascular system

A61P 11/00 Drugs for disorders of the respiratory system

Event Publications

7 January 2010 PCT application entered the National Phase

  PCT publication WO2008/156550 Priority application(s): WO2008/156550

23 August 2012 Application Accepted

  Published as AU-B-2008267058 ( Modified Examination )

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2008267059-TAT signal peptides for producing proteins in prokaryotes

2008267052-Method and system for providing network and routing protocols for utility services